Loading...
 
Translate Register Log In Login with facebookLogin and Register

Diagnosed with breast cancer – take vitamin D to cut chance of death by half – July 2018

De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival.

Breast Cancer Res Treat. 2018 Jul 23. doi: 10.1007/s10549-018-4896-6. [Epub ahead of print]
Madden JM1, Murphy L2, Zgaga L3, Bennett K2.

Vitamin D Life

This is similar to many studies that have found that Vitamin D treats many health problems
Vitamin D has been proven to

  1. Kill the Cancer cells
  2. Make the chemotherapy more effective, thus smaller doses can be used
    Perhaps less chemotherapy will result in less hair loss
  3. Reduce risk of Cancer metastasis
  4. Reduce pain

Breast Cancer Studies

After Cancer Diagnosis Studies

see wikipage: http://www.vitad.org/tiki-index.php?page_id=396
         click on chart for details


PURPOSE:
Experimental laboratory data have indicated a protective effect of vitamin D on breast cancer progression, while epidemiological evidence is growing. Using pharmacy claims data, this study investigates the association between vitamin D supplement use initiated after a breast cancer diagnosis and associated mortality.

METHODS:
Women aged 50-80 years with a record of invasive breast cancer were identified on the National Cancer Registry Ireland database (n = 5417). Initiation of de novo vitamin D post-diagnosis was identified from linked national prescription data (n = 2581, 49%). Multivariate Cox proportional hazards models were used to estimate adjusted HRs (95% CIs) for breast cancer-specific mortality.

RESULTS:
There was a 20% reduction in breast cancer-specific mortality in de novo vitamin D users (modelled as a time-varying variable) compared to non-users (HR 0.80; 95% CI 0.64-0.99, p = 0.048) and the reduction was greater at 49% (HR 0.51; 95% CI 0.34-0.74, p < 0.001), if vitamin D was initiated soon after the breast cancer diagnosis (within 6 months).

CONCLUSIONS:
In this large national breast cancer cohort, de novo vitamin D use post-diagnosis was found to be associated with a reduction in breast cancer-specific mortality. Vitamin D, therefore, has the potential as a non-toxic and inexpensive agent to improve survival in breast cancer patients. Findings support the need for RCTs exploring the effect of vitamin D supplementation on breast cancer survival.

References

  • 1. Cashman KD, Dowling KG, Skrabakova Z, Gonzalez-Gross M, Valtuena J, De Henauw S et al (2016) Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 103(4):1033–1044
  • 2. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035
    Vitamin D Life 137 health problems associated with low vitamin D – meta-meta-analysis April 2014
  • 3. Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J (2017) Vitamin D analogues: potential use in cancer treatment. Crit Rev Oncol/Hematol 112:190–197
  • 4. Kim Y, Je Y (2014) Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 110(11):2772–2784
  • 5. Vaughan-Shaw PG, O’Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer 116(8):1092–1110
  • 6. Bolland MJ, Grey A, Gamble GD, Reid IR (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94(4):1144–1149
  • 7. Sperati F, Vici P, Maugeri-Sacca M, Stranges S, Santesso N, Mariani L et al (2013) Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PloS ONE 8(7):e69269
  • 8. Keum N, Giovannucci E (2014) Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer 111(5):976–980
  • 9. Pradhan AD, Manson JE (2016) Update on the Vitamin D and OmegA-3 trial (VITAL). J Steroid Biochem Mol Biol 155(Pt B ):252–256
  • 10. Augustin LSA, Libra M, Crispo A, Grimaldi M, De Laurentiis M, Rinaldo M et al (2017) Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial. BMC Cancer 17:69
  • 11. Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W et al (2013) Postdiagnosis supplement use and breast cancer prognosis in the after breast cancer pooling project. Breast Cancer Res Treat 139(2):529–537
  • 12. Gallagher CM, More K, Kamath T, Masaquel A, Guerin A, Ionescu-Ittu R et al (2016) Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer. Breast Cancer Res Treat 157(1):145–156
  • 13. Raphael MJ, Biagi JJ, Kong W, Mates M, Booth CM, Mackillop WJ (2016) The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 160(1):17–28
  • 14. Mazidi M, Rezaie P, Vatanparast H, Kengne AP (2017) Effect of statins on serum vitamin D concentrations: a systematic review and meta-analysis. Eur J Clin Investig 47(1):93–101
  • 15. O’Brien K, Comber H, Sharp L (2014) Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci 183(2):219–224
  • 16. Barron TI, Cahir C, Sharp L, Bennett K (2013) A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Br J Cancer 109(6):1513–1521
  • 17. Sinnott SJ, Bennett K, Cahir C (2017) Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. Eur J Clin Pharmacol 73(11):1449–1455
  • 18. Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM (2013) Developing a protocol for observational comparative effectiveness research: A user’s guide. Agency for Healthcare Research and Quality
  • 19. Lund JL, Richardson DB, Sturmer T (2015) The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep 2(4):221–228
  • 20. Suissa S (2008) Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167(4):492–499
  • 21. Vitamin D and Health (2016) The Scientific Advisory Committee on Nutrition (SACN) UK
  • 22. Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L (2015) De novo post-diagnosis aspirin use and mortality in women with stage i–iii breast cancer. Cancer Epidemiol Biomark Prev 24(6):898–904
  • 23. Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I et al (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386(10001):1353–1361
  • 24. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11):805–812
  • 25. Schneeweiss S, Maclure M (2000) Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 29(5):891–898
  • 26. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154(9):854–864
  • 27. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20):1584–1598
  • 28. Smith A, Murphy L, Bennett K, Barron TI (2017) Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life. Supportive Care Cancer 25(5):1629–1637
  • 29. Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46(3):399–424
  • 30. Jeffreys M, Redaniel MT, Martin RM (2015) The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink. BMC Cancer 15:670
  • 31. Li M, Chen P, Li J, Chu R, Xie D, Wang H (2014) Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 99(7):2327–2336
  • 32. Maalmi H, Ordonez-Mena JM, Schottker B, Brenner H (2014) Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur J Cancer 50(8):1510–1521
  • 33. Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT et al (2014) Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer 14:382
  • 34. Heaney RP (2008) Vitamin D in health and disease. Clin J Am Soc Nephrol 3(5):1535–1541
  • 35. Rose AA, Elser C, Ennis M, Goodwin PJ (2013) Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Res Treat 141(3):331–339
  • 36. Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ et al (2015) Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer 15(1):e1–e11
  • 37. Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS (2013) Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst 105(19):1456–1462
  • 38. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A et al (2010) 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity 18(10):1906–1910
  • 39. Kennel KA, Drake MT (2013) Vitamin D in the cancer patient. Curr Opin Support Palliat Care 7(3):272–277
  • 40. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121(2):469–477

Created by admin. Last Modification: Monday September 10, 2018 00:29:26 GMT-0000 by admin. (Version 4)
See any problem with this page? Report it (FINALLY WORKS)